A key Senate panel voted today to confirm Robert F. Kennedy Jr. as President Donald Trump’s (R) controversial pick to [...] …
Category: General
Several major 340B service companies announced mergers and acquisitions this week that officials said will expand their offerings and resources [...] …
Robert F. Kennedy Jr., President Donald Trump’s pick to lead the U.S. Department of Health and Human Services (HHS), fielded [...] …
Robert F. Kennedy Jr., President Donald Trump’s (R) Health and Human Services (HHS) secretary nominee, offered support for pharmacy benefit [...] …
The Trump Administration indicated Wednesday that it will continue the Inflation Reduction Act’s (IRA) Medicare drug price negotiations, a signature [...] …
Congressional Republicans are considering a contentious proposal that would prohibit 340B covered entities from charging employer-sponsored commercial insurance plans full [...] …
Exclusive
Dr. Oz, Trump’s Pick to Lead CMS, Linked to Senior Role in Company that Partners With 340B Hospitals
Mehmet Oz, the celebrity heart surgeon and former U.S. Senate candidate that President Donald Trump nominated to lead the Centers [...] …
Senate Sets Confirmation Hearings for RFK Jr.’s HHS Secretary Nomination, HHS Freezes Communications
Robert F. Kennedy Jr., President Donald Trump’s (R) controversial pick to lead the U.S. Department of Health and Human Services [...] …
SPONSORED CONTENT
The evolving landscape of pharmaceutical pricing and reimbursement models presents complex challenges for manufacturers and pharmacies. One of the most significant developments is the introduction of the Inflation Reduction Act (IRA) and its Maximum Fair Price (MFP) provisions, aimed at reducing drug
…